From Transplants to CAR T-Cell Therapy

Procedures involving stem cell and bone marrow transplants were one of the first successful forms of immunotherapy in cancer care. Recent scientific and medical advances have led to novel approaches making transplant safer and more effective than ever before. Innovations continue to transform the field, offering alternative treatments that help the body’s immune system better recognize and fight the cancer. CAR T-cell therapy is one example which has demonstrated promising results and continues to be studied in clinical trials across a variety of diseases.


Guest: Koen Van Besien, MD, PhD, hematologist and medical oncologist, Director of Bone Marrow and Stem Cell Transplant Program, and Director of Cellular Therapy Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital. 

Host: John Leonard, MD, world-renowned hematologist and medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital.